S. Walker, Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transplant infectious disease : an official journal of the, Transplantation Society, vol.9, pp.165-170, 2007.

A. J. Eid, A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection, Transplant International, vol.9, issue.5, pp.506-513, 2010.
DOI : 10.1111/j.1432-2277.2009.01017.x

L. Rosa, C. Limaye, A. P. Krishnan, A. Longmate, J. Diamond et al., Longitudinal Assessment of Cytomegalovirus (CMV)???Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease, The Journal of Infectious Diseases, vol.195, issue.5, pp.633-644, 2007.
DOI : 10.1086/511307

C. Costa, Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients, Transplantation Proceedings, vol.43, issue.4, pp.1159-1161, 2011.
DOI : 10.1016/j.transproceed.2011.03.024

A. Chiereghin, Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients, Transplantation Proceedings, vol.42, issue.1, pp.69-73, 2010.
DOI : 10.1016/j.transproceed.2009.12.030

M. Patel, Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients, Pediatric Transplantation, vol.29, issue.Suppl 1, pp.18-28, 2012.
DOI : 10.1111/j.1399-3046.2011.01531.x

G. P. Westall, N. A. Mifsud, and T. Kotsimbos, T-Cell Immunity, American Journal of Transplantation, vol.176, issue.8, pp.1749-1754, 2008.
DOI : 10.1111/j.1600-6143.2008.02294.x

L. F. Lisboa, D. Kumar, L. E. Wilson, and A. Humar, Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia, Transplantation, vol.93, issue.2, pp.195-200, 2012.
DOI : 10.1097/TP.0b013e31823c1cd4

T. Bunde, Protection from cytomegalovirus after transplantation is correlated with immediate early 1???specific CD8 T cells, The Journal of Experimental Medicine, vol.26, issue.7, pp.1031-1036, 2005.
DOI : 10.1146/annurev.iy.13.040195.002553

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213133

M. R. Pipeling, E. R. John, J. B. Orens, N. Lechtzin, and J. Mcdyer, Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients, Journal of Infectious Diseases, vol.204, issue.11, pp.1663-1671, 2011.
DOI : 10.1093/infdis/jir624

L. Page and A. K. , Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients, Clinical Infectious Diseases, vol.56, issue.7, pp.1018-1029, 2013.
DOI : 10.1093/cid/cis1035

V. C. Emery and P. Griffiths, Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.8039-8044, 2000.
DOI : 10.1073/pnas.140123497

G. Nebbia, Polyfunctional Cytomegalovirus-Specific CD4+ and pp65 CD8+ T Cells Protect Against High-Level Replication After Liver Transplantation, American Journal of Transplantation, vol.273, issue.12, pp.2590-2599, 2008.
DOI : 10.1111/j.1600-6143.2008.02425.x

T. W. Kuijpers, Frequencies of Circulating Cytolytic, CD45RA+CD27-, CD8+ T Lymphocytes Depend on Infection with CMV, The Journal of Immunology, vol.170, issue.8, pp.4342-4348, 1950.
DOI : 10.4049/jimmunol.170.8.4342

X. Zhang, Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1, Immunity, vol.20, issue.3, pp.337-347, 2004.
DOI : 10.1016/S1074-7613(04)00051-2

C. A. Benedict, A. Loewendorf, Z. Garcia, B. R. Blazar, and E. M. Janssen, Dendritic Cell Programming by Cytomegalovirus Stunts Naive T Cell Responses via the PD-L1/PD-1 Pathway, The Journal of Immunology, vol.180, issue.7, pp.4836-4847, 1950.
DOI : 10.4049/jimmunol.180.7.4836

J. Dirks, CD4 T Cells Allows Stimulation-Independent Assessment of CMV Viremic Episodes in Transplant Recipients, American Journal of Transplantation, vol.205, issue.12, pp.3132-3141, 2013.
DOI : 10.1111/ajt.12480

L. Rosa and C. , Programmed Death???1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease, The Journal of Infectious Diseases, vol.197, issue.1, pp.25-33, 2008.
DOI : 10.1086/523652

R. 1. Smith, C. Miles, J. J. Khanna, and R. , Advances in Direct T-Cell Alloreactivity: Function, Avidity, Biophysics and Structure, American Journal of Transplantation, vol.91, issue.1, pp.15-26, 2012.
DOI : 10.1111/j.1600-6143.2011.03863.x

M. K. Gandhi and R. Khanna, Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. The Lancet infectious diseases 4, pp.725-738, 2004.
DOI : 10.1016/s1473-3099(04)01202-2

J. Dechanet, Major Expansion of ???? T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients, The Journal of Infectious Diseases, vol.179, issue.1, pp.1-8, 1999.
DOI : 10.1086/314568

J. Dechanet, Implication of ???? T cells in the human immune response to cytomegalovirus, Journal of Clinical Investigation, vol.103, issue.10, pp.1437-1449, 1999.
DOI : 10.1172/JCI5409

D. Abate, Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients, Journal of Clinical Microbiology, vol.51, issue.8, pp.2501-2507, 2013.
DOI : 10.1128/JCM.00563-13

D. Abate, Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants, Journal of Virological Methods, vol.196, 2013.
DOI : 10.1016/j.jviromet.2013.10.036

T. Schmidt and M. Sester, Detection of Antigen-Specific T Cells Based on Intracellular Cytokine Staining Using Flow-Cytometry, Methods in molecular biology, vol.1064, pp.267-274, 2013.
DOI : 10.1007/978-1-62703-601-6_19

R. A. Brooimans, Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes, Cytometry Part A, vol.100, issue.11, pp.992-1000, 2008.
DOI : 10.1002/cyto.a.20641

A. Humar, The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients, American Journal of Transplantation, vol.7, issue.Suppl 10, pp.1228-1237, 2010.
DOI : 10.1111/j.1600-6143.2010.03074.x

L. Couzi, High Incidence of Anticytomegalovirus Drug Resistance Among D+R??? Kidney Transplant Recipients Receiving Preemptive Therapy, American Journal of Transplantation, vol.4, issue.1, pp.202-209, 2012.
DOI : 10.1111/j.1600-6143.2011.03766.x

URL : https://hal.archives-ouvertes.fr/hal-00675701

D. Abate, Evaluation of Cytomegalovirus (CMV)???Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV???Specific T Cell Reconstitution in Kidney Transplant Recipients, The Journal of Infectious Diseases, vol.202, issue.4, pp.585-594, 2010.
DOI : 10.1086/654931

R. Radha, Cellular Immune Responses to Cytomegalovirus in Renal Transplant Recipients, American Journal of Transplantation, vol.175, issue.1, pp.110-117, 2005.
DOI : 10.1182/blood-2002-08-2502

L. Rosa, C. Limaye, A. P. Krishnan, A. Longmate, J. Diamond et al., Longitudinal Assessment of Cytomegalovirus (CMV)???Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease, The Journal of Infectious Diseases, vol.195, issue.5, pp.633-644, 2007.
DOI : 10.1086/511307

A. Egli, Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients, Journal of Translational Medicine, vol.6, issue.1, p.29, 2008.
DOI : 10.1186/1479-5876-6-29

M. R. Pipeling, E. R. John, J. B. Orens, N. Lechtzin, and J. Mcdyer, Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients, Journal of Infectious Diseases, vol.204, issue.11, pp.1663-1671, 2011.
DOI : 10.1093/infdis/jir624

G. P. Westall, N. A. Mifsud, and T. Kotsimbos, T-Cell Immunity, American Journal of Transplantation, vol.176, issue.8, pp.1749-1754, 2008.
DOI : 10.1111/j.1600-6143.2008.02294.x

D. Kumar, Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients, American Journal of Transplantation, vol.8, issue.s10, pp.1214-1222, 2009.
DOI : 10.1111/j.1600-6143.2009.02618.x

L. F. Lisboa, D. Kumar, L. E. Wilson, and A. Humar, Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia, Transplantation, vol.93, issue.2, pp.195-200, 2012.
DOI : 10.1097/TP.0b013e31823c1cd4

L. Weseslindtner, Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients, American Journal of Transplantation, vol.36, issue.Suppl 3, pp.2172-2180, 2012.
DOI : 10.1111/j.1600-6143.2012.04076.x

O. Manuel, Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study, Clinical Infectious Diseases, vol.56, issue.6, pp.817-824, 2013.
DOI : 10.1093/cid/cis993

A. Asberg, Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients, American Journal of Transplantation, vol.55, issue.10, pp.2106-2113, 2007.
DOI : 10.1038/sj.icb.7100013

R. A. Metzger, Expanded criteria donors for kidney transplantation, American Journal of Transplantation, vol.1, issue.4, pp.114-125, 2003.
DOI : 10.1093/ndt/17.8.1497

O. H. Koning, RISK FACTORS FOR DELAYED GRAFT FUNCTION IN CADAVERIC KIDNEY TRANSPLANTATION, Transplantation, vol.63, issue.11, pp.1620-1628, 1997.
DOI : 10.1097/00007890-199706150-00015

I. Garrigue, Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood Load in Samples from Renal Transplant Recipients, Journal of Clinical Microbiology, vol.46, issue.2, pp.493-498, 2008.
DOI : 10.1128/JCM.01499-07

S. Chou, Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis, Transplantation, vol.90, issue.12, pp.1409-1413, 2010.
DOI : 10.1097/TP.0b013e3181fdd9d2

S. Hantz, Drug-resistant cytomegalovirus in transplant recipients: a French cohort study, Journal of Antimicrobial Chemotherapy, vol.65, issue.12, pp.2628-2640, 2010.
DOI : 10.1093/jac/dkq368

URL : https://hal.archives-ouvertes.fr/inserm-00533269

R. C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2012.

J. A. Khoury, Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients, American Journal of Transplantation, vol.95, issue.9, pp.2134-2143, 2006.
DOI : 10.1111/j.1600-6143.2005.00742.x

V. Kliem, Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial, American Journal of Transplantation, vol.1, issue.2, pp.975-983, 2008.
DOI : 10.1097/01.TP.0000142619.01510.A5

T. Reischig, Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation, American Journal of Transplantation, vol.324, issue.2, pp.69-77, 2008.
DOI : 10.1097/00007890-200011270-00012

O. Witzke, Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial, Transplantation, vol.93, issue.1, pp.61-68, 2012.
DOI : 10.1097/TP.0b013e318238dab3

C. N. Kotton, Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation, Transplantation Journal, vol.96, issue.4, pp.333-360, 2013.
DOI : 10.1097/TP.0b013e31829df29d

S. K. Arthurs, Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation, Clinical Infectious Diseases, vol.46, issue.6, pp.840-846, 2008.
DOI : 10.1086/528718

S. Cantisan, Pretransplant Interferon-?? Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation, American Journal of Transplantation, vol.49, issue.3, pp.738-745, 2013.
DOI : 10.1111/ajt.12049

D. Abate, Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants, Journal of Virological Methods, vol.196, pp.157-162, 2014.
DOI : 10.1016/j.jviromet.2013.10.036

A. J. Eid, A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection, Transplant International, vol.9, issue.5, pp.506-513, 2010.
DOI : 10.1111/j.1432-2277.2009.01017.x

T. Bunde, Protection from cytomegalovirus after transplantation is correlated with immediate early 1???specific CD8 T cells, The Journal of Experimental Medicine, vol.26, issue.7, pp.1031-1036, 2005.
DOI : 10.1146/annurev.iy.13.040195.002553

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213133

C. Costa, Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients, Transplantation Proceedings, vol.43, issue.4, pp.1159-1161, 2011.
DOI : 10.1016/j.transproceed.2011.03.024

M. Patel, Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients, Pediatric Transplantation, vol.29, issue.Suppl 1, pp.18-28, 2012.
DOI : 10.1111/j.1399-3046.2011.01531.x

A. P. Limaye, Ganciclovir-resistant cytomegalovirus in organ transplant recipients Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.35, pp.866-872, 2002.

L. Page and A. K. , Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients, Clinical Infectious Diseases, vol.56, issue.7, pp.1018-1029, 2013.
DOI : 10.1093/cid/cis1035

V. C. Emery and P. Griffiths, Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.8039-8044, 2000.
DOI : 10.1073/pnas.140123497

A. P. Limaye, L. Corey, D. M. Koelle, C. L. Davis, and M. Boeckh, Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants, The Lancet, vol.356, issue.9230, pp.645-649, 2000.
DOI : 10.1016/S0140-6736(00)02607-6

H. A. Myhre, Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients, Transplantation, vol.92, issue.2, pp.217-223, 2011.
DOI : 10.1097/TP.0b013e31821fad25

C. L. Day, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006.
DOI : 10.1126/science.274.5284.94